1. Home
  2. TNGX
  3. TNGX News

Latest Tango Therapeutics Inc. (TNGX) News on May 28, 2024

Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program

PR Newswire

5 days ago

Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program

Thomson Reuters StreetEvents

4 months ago

Q4 2023 WesBanco Inc Earnings Call

Associated Press Finance

4 months ago

K12: Fiscal Q2 Earnings Snapshot

Thomson Reuters StreetEvents

7 months ago

Q3 2023 Sitio Royalties Corp Earnings Call

These Top Stocks Boast The Highest IBD Ratings

Investor's Business Daily

7 months ago

These Top Stocks Boast The Highest IBD Ratings

Share on Social Networks: